A. Mizokami

M. Yasuda, T. Deguchi, K. Nakashima, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp

T. Sasagawa, K. Nakashima, Y. Kitagawa, 2014, BMC Infectious Diseases.

Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)

H. Akaza, Y. Kitagawa, A. Mizokami, 2017, Prostate international.

Real-World Clinical Outcomes of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

K. Izumi, A. Mizokami, K. Shigehara, 2020 .

Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study.

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Japanese journal of clinical oncology.

Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.

H. Akaza, Y. Tomita, M. Fujisawa, 2014, Japanese journal of clinical oncology.

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Anticancer research.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT‐BSI) study

K. Harada, K. Nakajima, H. Shiina, 2018, International journal of urology : official journal of the Japanese Urological Association.

Interleukin‐6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation

K. Iguchi, Takeshi Sasaki, A. Mizokami, 2018, The Prostate.

Heterogenous induction of carcinoma‐associated fibroblast‐like differentiation in normal human prostatic fibroblasts by co‐culturing with prostate cancer cells

K. Iguchi, T. Tsunoda, A. Mizokami, 2011, Journal of cellular biochemistry.

Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) study.

S. Horie, Y. Kondo, T. Fukagai, 2013, Anticancer research.

A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study

H. Yaegashi, K. Nakashima, K. Izumi, 2021, Scientific Reports.

Primary combined androgen blockade in localized disease and its mechanism.

Y. Kitagawa, A. Mizokami, M. Namiki, 2008, Best practice & research. Clinical endocrinology & metabolism.

Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)

H. Kume, H. Nishiyama, T. Mitsui, 2022, International journal of urology : official journal of the Japanese Urological Association.

First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice

K. Izumi, A. Mizokami, Renato Naito, 2020, Translational andrology and urology.

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)

H. Akaza, K. Izumi, Y. Kitagawa, 2014, Journal of Cancer Research and Clinical Oncology.

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan

H. Yaegashi, K. Nakashima, K. Izumi, 2014, Asian journal of andrology.

5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.

K. Izumi, A. Mizokami, Yohei Saito, 2018, European journal of medicinal chemistry.

Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer

Kyoko Takahashi, K. Izumi, A. Mizokami, 2021, ACS omega.

CCL5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment

Wen-Jye Lin, K. Izumi, A. Mizokami, 2018 .

Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer

L. Edenbrandt, K. Nakajima, A. Mizokami, 2017, International journal of urology : official journal of the Japanese Urological Association.

Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.

P. Quesenberry, G. Camussi, E. Keller, 2015, Critical reviews in oncogenesis.

Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas.

K. Nakashima, K. Izumi, Y. Kitagawa, 2016, Oncology letters.

Global update on defining and treating high‐risk localized prostate cancer with leuprorelin: an Asian perspective

H. Akaza, Kazuto Ito, S. Ueno, 2007, BJU international.

Impact of pre‐treatment prostate tissue androgen content on the prediction of castration‐resistant prostate cancer development in patients treated with primary androgen deprivation therapy

N. Nonomura, N. Masumori, Y. Kubota, 2013, Andrology.

Factors Associated With Treatment Satisfaction After Robot-assisted Radical Prostatectomy

H. Yaegashi, K. Izumi, A. Mizokami, 2019, AntiCancer Research.

Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial

N. Kawai, H. Enokida, T. Okamura, 2022, European urology open science.

Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy

H. Yaegashi, K. Nakajima, K. Nakashima, 2019, AntiCancer Research.

Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy

E. Nice, Zhe Zhang, Li Zhou, 2022, EMBO molecular medicine.

Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Cancers.

Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2020, AntiCancer Research.

The correlation between highly sensitive C-reactive protein levels and erectile function among men with late-onset hypogonadism

Y. Kitagawa, A. Mizokami, M. Namiki, 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

E. Keller, Y. Kitagawa, A. Mizokami, 2013, The Prostate.

Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic Protein

R. Taichman, Shiyuan Cheng, Jian Zhang, 2004, Cancer Research.

Title Reconsideration of progression to CRPC during androgen deprivationtherapy

A. Mizokami, M. Namiki, 2017 .

Reconsideration of progression to CRPC during androgen deprivation therapy

A. Mizokami, M. Namiki, 2015, The Journal of Steroid Biochemistry and Molecular Biology.

Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study)

K. Nakashima, T. Iwamoto, Y. Kitagawa, 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

Bisphosphonate induces apoptosis and inhibits pro‐osteoclastic gene expression in prostate cancer cells

E. Keller, A. Mizokami, M. Namiki, 2006, International journal of urology : official journal of the Japanese Urological Association.

Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.

E. Keller, J. Escara-Wilke, A. Mizokami, 2008, Cancer research.

The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.

R. Taichman, Jian Zhang, E. Keller, 2005, Cancer research.

Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

Yi Lu, Jian Zhang, E. Keller, 2010, Cancer research.

Testosterone Deficiency and Nocturia: A Review

A. Mizokami, M. Namiki, K. Shigehara, 2017, The world journal of men's health.

Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan

T. Iwamoto, Y. Kitagawa, A. Mizokami, 2015, The aging male : the official journal of the International Society for the Study of the Aging Male.

Lower Urinary Tract Symptoms are Associated with Erectile Function and Psychological Symptoms in Men with Late‐Onset Hypogonadism Syndrome

Y. Kitagawa, A. Mizokami, M. Namiki, 2014, Lower urinary tract symptoms.

Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study

H. Yaegashi, Y. Kitagawa, A. Mizokami, 2014, The aging male : the official journal of the International Society for the Study of the Aging Male.

Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus

K. Nakashima, K. Izumi, A. Mizokami, 2018, International Journal of Impotence Research.

The Effects of Cyclooxygenase-2 Expression in Prostate Cancer Cells: Modulation of Response to Cytotoxic Agents

H. Coley, G. Kass, A. Mizokami, 2008, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of growth and increase of acid phosphatase by testosterone on androgen‐independent murine prostatic cancer cells transfected with androgen receptor cDNA

N. Sato, A. Mizokami, T. Ichikawa, 1994, The Prostate.

The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells.

N. Yanagihara, A. Mizokami, O. Ishida, 1994, Bone and mineral.

Title High testosterone levels in prostate tissue obtained by needle biopsycorrelate with poor-prognosis factors in prostate cancer patients

S. Morita, N. Nonomura, N. Masumori, 2019 .

synthesis of T and DHT from DHEA.

K. Izumi, A. Mizokami, K. Narimoto, 2009 .

Induction of translation by the 5'-untranslated region of human androgen receptor mRNA.

C. Chang, A. Mizokami, C. Chang, 1994, The Journal of biological chemistry.

The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function

T. Iwamoto, A. Mizokami, M. Namiki, 2009, International Journal of Impotence Research.

Influence of the Coronavirus Disease 2019 Vaccine on Drug Therapy for Urological Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2022, AntiCancer Research.

Epigenetic Regulation of Androgen Receptor Gene Expression in Human Prostate Cancers

M. Toyota, Masatoshi Watanabe, A. Mizokami, 2000, Laboratory Investigation.

Low serum dehydroepiandrosterone examined by liquid chromatography‐tandem mass spectrometry correlates with poor prognosis in hormone‐naïve prostate cancer

M. Taguri, N. Nonomura, N. Masumori, 2016, The Prostate.

Epidemiology and Prevention of Renal Cell Carcinoma

K. Izumi, A. Mizokami, Suguru Kadomoto, 2022, Cancers.

Test clamp procedure in robot-assisted partial nephrectomy: is it a safe procedure?

H. Yaegashi, K. Izumi, A. Mizokami, 2021, Journal of Robotic Surgery.

K. Nakashima, K. Izumi, A. Mizokami, 2019, Anticancer Research.

[Production of polyclonal antibody against human androgen receptor and immunohistochemical study of human androgen receptor in prostatic tissues].

A. Mizokami, M. Masai, J. Shimazaki, 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Prostate Cancer Cells Increase Androgen Sensitivity by Increase in Nuclear Androgen Receptor and Androgen Receptor Coactivators; A Possible Mechanism of Hormone-Resistance of Prostate Cancer Cells

Y. Ueta, T. Sasaguri, H. Miyamoto, 2007, Cancer investigation.

Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Asian journal of andrology.

IMMUNOHISTOCHEMICAL EVALUATION OF THE EFFECT OF TZP-4238-POSSIBLE ANDROGEN RECEPTOR ANTAGONIST IN RAT PROSTATE

Minoru Suzuki, A. Mizokami, M. Murakoshi, 1993 .

Inhibition of Steroid-induced Prostatic Hyperplasia by Treatment with Anti-Androgen (TZP-4238) in Rats

Keiichi Watanabe, A. Mizokami, M. Murakoshi, 2006 .

HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDIES OF THE RAT DORSOLATERAL PROSTATE

Minoru Suzuki, Keiichi Watanabe, A. Mizokami, 1994 .

Inhibition of steroid-induced prostatic hyperplasia in rats by treatment with anti-androgen (TZP-4238).

A. Mizokami, M. Suzuki, M. Murakoshi, 1993, Endocrine journal.

Histopathological and immunohistochemical studies of the rat dorsolateral prostate. Effects of testosterone and testosterone plus estrogen

Minoru Suzuki, Keiichi Watanabe, A. Mizokami, 1993 .

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as second-line hormonal therapy

K. Izumi, A. Mizokami, M. Namiki, 2009 .

Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter.

S. Yeh, Chawnshang Chang, C. Chang, 1994, Molecular endocrinology.

Treatment strategies and outcomes in a long‐term registry study of patients with high‐risk metastatic hormone‐naïve prostate cancer in Japan: An interim analysis of the J‐ROCK study

T. Kamoto, H. Matsuyama, K. Fujimoto, 2022, International journal of urology : official journal of the Japanese Urological Association.

Prospective longitudinal comparative study of health-related quality of life and treatment satisfaction in patients treated with hormone therapy, radical retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer

Y. Kitagawa, A. Mizokami, M. Namiki, 2013, Prostate international.

Mediated by Bone Morphogenetic Protein Prostate Cancer-Induced Osteoblast Differentiation Vascular Endothelial Growth Factor Contributes to the Updated

R. Taichman, Shiyuan Cheng, Jian Zhang, 2004 .

Running Head: Pembrolizumab for UC with small lesions-Kadono et al. Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST

K. Izumi, A. Mizokami, K. Shigehara, 2021 .

The effectiveness of interferon-alpha subtypes alternation for metastasis from renal cell carcinoma.

A. Mizokami, M. Namiki, A. Hirata, 2012, Biomedical research.

Myelodysplastic syndrome treated effectively with testosterone enanthate

A. Mizokami, M. Namiki, K. Shigehara, 2011, International journal of urology : official journal of the Japanese Urological Association.

Treatment at an Inexperienced Center Suggests Worse Prognosis of Metastatic Germ Cell Tumors.

H. Yaegashi, K. Izumi, A. Mizokami, 2021, Cancer diagnosis & prognosis.

Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases

H. Miyake, T. Yoneda, U. Tateishi, 2018, Oncology and Therapy.

Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.

Y. Hayashi, H. Ikeda, M. Nakada, 2016, World neurosurgery.

Gonadal function and testicular histology in males with Prader‐Willi syndrome

S. Ida, A. Mizokami, F. Matsui, 2018, Endocrinology, diabetes & metabolism.

Determination of prostatic androgens in 10 mg of tissue using liquid chromatography–tandem mass spectrometry with charged derivatization

T. Higashi, A. Mizokami, M. Namiki, 2005, Analytical and bioanalytical chemistry.

Clinical Outcomes of Three or More Courses of First-line Chemotherapy for Metastatic Urothelial Carcinoma.

H. Yaegashi, K. Izumi, A. Mizokami, 2021, Cancer diagnosis & prognosis.

The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2020, AntiCancer Research.

Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.

K. Izumi, A. Mizokami, Hiroaki Iwamoto, 2016, Anticancer research.

Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract.

K. Izumi, A. Mizokami, Hiroaki Iwamoto, 2018, Anticancer research.

Imaging Somatostatin Receptor Activity in Neuroendocrine-differentiated Prostate Cancer

K. Nakajima, H. Ikeda, H. Wakabayashi, 2018, Internal medicine.

Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor

K. Izumi, A. Mizokami, Hiroaki Iwamoto, 2018, In Vivo.

Clinical characteristics and prostate‐specific antigen kinetics of prostate cancer detected in repeat annual population screening in Japan

Y. Kitagawa, A. Mizokami, M. Namiki, 2014, International journal of urology : official journal of the Japanese Urological Association.

Cumulative probability of prostate cancer detection using the international prostate symptom score in a prostate-specific antigen-based population screening program in Japan.

K. Izumi, Y. Kitagawa, A. Mizokami, 2014, Asian Pacific journal of cancer prevention : APJCP.

Selection of adjuvant intravesical therapies using the European Organization for Research and Treatment of Cancer scoring system in patients at intermediate risk of non-muscle-invasive bladder cancer

H. Yaegashi, K. Izumi, Y. Kitagawa, 2014, Journal of Cancer Research and Clinical Oncology.

Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study

T. Shimada, Y. Sai, K. Izumi, 2017, Journal of Pharmaceutical Health Care and Sciences.

Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Frontiers in Oncology.

Downregulation of thymosin beta4 expression by androgen in prostate cancer LNCaP cells.

K. Iguchi, S. Usui, K. Hirano, 2007, Journal of andrology.

Effectiveness of Synthetic Polymer-coated Peripherally Inserted Central Catheter in Patients With Advanced Cancer

K. Izumi, A. Mizokami, Hiroaki Iwamoto, 2019, In Vivo.

Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review

K. Izumi, A. Mizokami, K. Shigehara, 2022, Journal of clinical medicine.

Immunohistochemical study of androgen receptor in rat prostatic hyperplasia : effect of anti-androgen TZP-4238

Minoru Suzuki, A. Mizokami, M. Murakoshi, 1994 .

EFFECTS OF ANTI-ANDROGEN, TZP-4238 AND CHLORMADINONE ACETATE ON THE ADRENAL CORTEX

Minoru Suzuki, Keiichi Watanabe, A. Mizokami, 1994 .

The correlation between erectile function and adiponectin levels in men with late-onset hypogonadism

K. Izumi, A. Mizokami, M. Namiki, 2022, The aging male : the official journal of the International Society for the Study of the Aging Male.

A Novel Scoring System to Predict the Risk for Disseminated Intravascular Coagulation in Obstructive Pyelonephritis Complicated with Upper Urinary Tract Calculi

K. Izumi, A. Mizokami, Hiroaki Iwamoto, 2019 .

Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2022, IJU case reports.

A new flavonoid derivative exerts antitumor effects against androgen‐sensitive to cabazitaxel‐resistant prostate cancer cells

H. Yaegashi, K. Izumi, A. Mizokami, 2021, The Prostate.

Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone.

Jian Zhang, E. Keller, K. Izumi, 2013, Anticancer research.

Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis

K. Harada, H. Yaegashi, H. Shiina, 2022, AntiCancer Research.

Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice

H. Shiina, H. Enokida, H. Matsuyama, 2022, AntiCancer Research.

Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Anticancer Research.

Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.

K. Izumi, A. Mizokami, K. Shigehara, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

SHORT-TERM EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY ON RISK PREDICTORS FOR ARTERIOSCLEROSIS AMONG MEN WITH LATE-ONSET HYPOGONADISM: A CASE–CONTROL STUDY

K. Izumi, A. Mizokami, M. Namiki, 2020 .

[C]Fluciclovine (alias anti-[C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells

D. Schuster, M. Goodman, T. Nakanishi, 2015 .

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Biomedicines.

Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis

H. Yaegashi, K. Izumi, A. Mizokami, 2019, Cancers.

The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study

H. Yaegashi, K. Izumi, A. Mizokami, 2021, International Journal of Clinical Oncology.

Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.

Jian Zhang, E. Keller, K. Izumi, 2018, Anticancer research.

SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.

Jian Zhang, E. Keller, K. Izumi, 2014, Anticancer research.

Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.

Y. Kanai, S. Sakamoto, A. Mizokami, 2016, The Journal of urology.

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men

H. Yaegashi, Kotaro Yoshida, K. Izumi, 2022, Cancers.

Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan.

H. Yaegashi, K. Nakashima, T. Kitamura, 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Androgen replacement therapy for cancer-related symptoms in male advanced cancer patients: study protocol for a randomised prospective trial (ARTFORM study).

S. Yano, K. Ohtsubo, Tadaaki Yamada, 2017, The journal of medical investigation : JMI.

A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation

H. Yaegashi, K. Nakashima, K. Izumi, 2019, Urologia internationalis.

Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargement

A. Mizokami, K. Shigehara, 2018, International journal of urology : official journal of the Japanese Urological Association.

Human papillomavirus prevalence in the anus and urine among HIV-infected Japanese men who have sex with men.

H. Yaegashi, H. Ikeda, K. Nakashima, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction

Y. Kitagawa, A. Mizokami, M. Namiki, 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

Active estrogen synthesis and its function in prostate cancer-derived stromal cells.

K. Izumi, A. Mizokami, M. Namiki, 2015, Anticancer research.

Use of preoperative factors including urodynamic evaluations and nerve‐sparing status for predicting urinary continence recovery after robot‐assisted radical prostatectomy: Nerve‐sparing technique contributes to the reduction of postprostatectomy incontinence

K. Nakashima, K. Izumi, A. Mizokami, 2016, Neurourology and urodynamics.

Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer

K. Harada, H. Shiina, M. Oyama, 2022, International journal of urology : official journal of the Japanese Urological Association.

Differential induction of androgen receptor transactivation by different androgen receptor coativators in human prostate cancer DU 145 cells

Hong-Chiang Chang, S. Yeh, Chawnshang Chang, 1999, Endocrine.

Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate*

S. Inui, Hong-Chiang Chang, S. Yeh, 1999, The Journal of Biological Chemistry.

Urinary Obstruction of Transplanted Kidney Caused by Uterine Adenomyosis and 2-Year Posthysterectomy Psoas Abscess in Conjunction with Transplanted Kidney

A. Mizokami, Yuta Takezawa, Y. Kadono, 2016, Case reports in transplantation.

Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases

H. Yaegashi, K. Nakashima, K. Izumi, 2018, International Cancer Conference Journal.

Case of acute urinary retention as a result of non‐steroidal anti‐inflammatory drugs

A. Mizokami, M. Namiki, H. Minami, 2007, International journal of urology : official journal of the Japanese Urological Association.

Androgen receptor roles in the development of benign prostate hyperplasia.

Chawnshang Chang, Wen-Jye Lin, K. Izumi, 2013, The American journal of pathology.

Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance

E. Keller, J. Escara-Wilke, A. Mizokami, 2017, Molecular Cancer Research.

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer

Shiladitya Sengupta, B. Zetter, C. Barrows, 2021, Frontiers in Oncology.

Simultaneous determination of androstenediol 3-sulfate and dehydroepiandrosterone sulfate in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry.

A. Mizokami, M. Namiki, E. Koh, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment

K. Izumi, A. Mizokami, S. Kadomoto, 2021, International journal of molecular sciences.

Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma

Ritsuko Nakamura, A. Mizokami, M. Namiki, 2015, Cancer science.

Three-Dimensional Analysis of Busulfan-Induced Spermatogenesis Disorder in Mice

A. Mizokami, S. Iseki, Taito Nakano, 2020, Frontiers in Cell and Developmental Biology.

Antitumor effect of radioimmunotherapy in a mouse model of testicular tumor with micrometastases defined by polymerase chain reaction.

K. Hirano, Takuma Sasaki, K. Yokoyama, 2002, Oncology reports.

Abstract. Germ cell tumors with somatic‐type malignancy (GCTSTM) are rare, and patients with GCTSTM have extremely poor prognoses with a median survival of nine

H. Yaegashi, K. Izumi, A. Mizokami, 2021 .

In vitro chemosensitivity test for human genito‐urinary tumors using collagen gel matrix

Takuma Sasaki, M. Egawa, A. Mizokami, 2005, International journal of urology : official journal of the Japanese Urological Association.

Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.

E. Keller, K. Izumi, A. Mizokami, 2009, Endocrine-related cancer.

Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

E. Keller, Di Cui, A. Mizokami, 2015, Clinical Cancer Research.

Macrophage Polarity and Disease Control

K. Izumi, A. Mizokami, S. Kadomoto, 2021, International journal of molecular sciences.

The CCL20-CCR6 Axis in Cancer Progression

K. Izumi, A. Mizokami, S. Kadomoto, 2020, International journal of molecular sciences.

Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells

P. Schnepp, Hui Jiang, E. Keller, 2020, Molecular Cancer Research.

FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway

Tomohiko Ichikawa, Takumi Endo, Takeshi Ueda, 2012, PloS one.

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment

K. Izumi, A. Mizokami, T. Makino, 2021, Biomedicines.

Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression*

T. H. van der Kwast, E. Diamandis, K. Jarvi, 2013, Molecular & Cellular Proteomics.

Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma

K. Izumi, A. Mizokami, K. Shigehara, 2021, AntiCancer Research.

Exosome-derived microRNAs contribute to prostate cancer chemoresistance.

Jing Li, Jian Zhang, Yi Lu, 2016, International journal of oncology.

Title Expression and regulatory effects on cancer cell behavior of NELL 1 andNELL 2 in human renal cell carcinoma

Ritsuko Nakamura, A. Mizokami, M. Namiki, 2017 .

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Frontiers in Oncology.

Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples

K. Izumi, A. Mizokami, K. Shigehara, 2022, Journal of medical virology.

Etiological role of human papillomavirus infection for inverted papilloma of the bladder

T. Sasagawa, J. Doorbar, Y. Kitagawa, 2011, Journal of medical virology.

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

B. Zetter, E. Voest, Z. Duan, 2011, Oncogene.

Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer

K. Yeung, Jian Zhang, E. Keller, 2015, The Prostate.

Ethinylestradiol improves prostate-specific antigen levels in pretreated castration-resistant prostate cancer patients.

K. Izumi, A. Mizokami, M. Namiki, 2010, Anticancer research.

Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.

K. Izumi, A. Mizokami, M. Namiki, 2011, The Journal of urology.

Metastasis SuppressorGeneRafKinase Inhibitor Protein ( RKIP ) Is aNovel Prognostic Marker in ProstateCancer

Peter J. Keller, R. Shah, A. Chinnaiyan, 2005 .

Down‐regulation of calcium/calmodulin‐dependent protein kinase kinase 2 by androgen deprivation induces castration‐resistant prostate cancer

Toru Miyagi, Jian Zhang, E. Keller, 2012, The Prostate.

Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells

K. Izumi, A. Mizokami, Yohei Saito, 2018, The Prostate.

Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation

K. Nastiuk, K. Izumi, A. Mizokami, 2018, Cancer science.

Predictors of persistent stress urinary incontinence after transvaginal mesh repair

A. Mizokami, K. Narimoto, M. Takeyama, 2018, BMC Women's Health.

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation

Chawnshang Chang, Lei Li, Wen-Jye Lin, 2013, EMBO molecular medicine.

Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma

K. Izumi, A. Mizokami, Y. Kadono, 2023, Biomedicines.

Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer

Chiung-Kuei Huang, H. Miyamoto, Wen-Jye Lin, 2015, Oncotarget.

Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer

K. Izumi, A. Mizokami, T. Makino, 2021, Cancers.

Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling

Yi Lu, Jian Zhang, E. Keller, 2017, Chinese journal of cancer.

Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study

K. Harada, K. Nakajima, H. Shiina, 2021, International journal of urology : official journal of the Japanese Urological Association.

Incidences of visceral metastases from prostate cancer increase after progression of castration-resistant status.

K. Izumi, A. Mizokami, Y. Kadono, 2018 .

Treatment Outcomes in Neuroendocrine Prostate Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2022, AntiCancer Research.

Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer

T. Shimada, H. Yaegashi, Y. Sai, 2020, AntiCancer Research.

Cranial nerve deficit caused by skull metastasis of prostate cancer: three Japanese castration-resistant prostate cancer cases

K. Izumi, A. Mizokami, M. Namiki, 2010, International Journal of Clinical Oncology.

Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy

K. Nakashima, K. Izumi, A. Mizokami, 2020, Translational andrology and urology.

Three‐dimensional reconstruction of testis cords/seminiferous tubules

A. Mizokami, S. Iseki, Hiroki Nakata, 2021, Reproductive medicine and biology.

PTHrP‐induced MCP‐1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro

D. Galson, G. Xiao, Yi Lu, 2007, International journal of cancer.

Preliminary results of tranilast treatment for patients with advanced castration-resistant prostate cancer.

K. Izumi, A. Mizokami, M. Namiki, 2010, Anticancer research.

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1‐associated osteoblastic changes

E. Keller, K. Izumi, Y. Kitagawa, 2009, The Prostate.

Massive Ascites in a Renal Transplant Patient after Laparoscopic Fenestration of a Lymphocele

A. Mizokami, Y. Kadono, T. Nohara, 2016, Case reports in transplantation.

Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells

S. Mooney, Yu Zeng, R. Getzenberg, 2011, Journal of cellular biochemistry.

Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines

Jian Zhang, E. Keller, K. Izumi, 2018, Oncotarget.

A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study

G. Kimura, S. Kinuya, Motonobu Nakamura, 2019, International Journal of Clinical Oncology.

Reply to Comment on “Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis” Cancers 2020, 12, 89

H. Yaegashi, K. Izumi, A. Mizokami, 2020, Cancers.

Etiologic role of human papillomavirus infection in bladder carcinoma

T. Sasagawa, A. Mizokami, M. Namiki, 2011, Cancer.

Molecular cloning and expression of a novel homeobox gene AHoxi of the ascidian, Halocynthia roretzi

N. Satoh, H. Saiga, K. Makabe, 2005 .

Molecular cloning and expression of a novel homeobox gene AHox1 of the ascidian, Halocynthia roretzi.

N. Satoh, H. Saiga, K. Makabe, 1991, Development.

Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial

N. Kawai, H. Enokida, N. Tanaka, 2017, BMC Cancer.

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

H. Ikeda, K. Izumi, Y. Kitagawa, 2015, The Prostate.

Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway

Yi Lu, Siyuan Qin, Jian Zhang, 2018, Oncotarget.

Androgen receptor: an overview.

A. Saltzman, S. Yeh, A. Mizokami, 1995, Critical reviews in eukaryotic gene expression.

Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion

Y. Kitagawa, A. Mizokami, M. Namiki, 2008, International Journal of Clinical Oncology.

Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP.

H. Saiga, A. Mizokami, T. Mita, 1992, Endocrinologia japonica.

Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis

H. Yaegashi, K. Nakajima, S. Kinuya, 2017, Annals of Nuclear Medicine.

Overexpression of p54nrb/NONO induces differential EPHA6 splicing and contributes to castration-resistant prostate cancer growth

H. Aburatani, T. Kodama, M. Anai, 2018, Oncotarget.

Cyclooxygenase‐2 promotes prostate cancer progression

H. Fujita, E. Keller, A. Mizokami, 2002, The Prostate.

Changes in penile length after radical prostatectomy: investigation of the underlying anatomical mechanism

K. Nakashima, K. Izumi, Y. Kitagawa, 2017, BJU international.

Comparison of two in vivo models for prostate cancer: Orthotopic and intratesticular inoculation of LNCaP or PC‐3 cells

M. Egawa, A. Mizokami, M. Namiki, 2004, International journal of urology : official journal of the Japanese Urological Association.

Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic

H. Yaegashi, K. Izumi, A. Mizokami, 2023 .

High‐dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer

A. Mizokami, M. Namiki, K. Koshida, 2002 .

Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells

T. Shimada, H. Yaegashi, T. Wada, 2021, Scientific reports.

A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.

K. Izumi, A. Mizokami, M. Namiki, 2009, Japanese journal of clinical oncology.

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells

K. Izumi, A. Mizokami, 2019, Journal of clinical medicine.

An important step in establishing a treatment strategy for small renal masses of clear cell renal cell carcinoma based on the significance of adverse histopathologic features on tumor needle biopsy.

K. Izumi, A. Mizokami, T. Makino, 2019, Annals of translational medicine.

The role of percutaneous needle biopsy in differentiation of renal tumors.

S. Yano, Tadaaki Yamada, K. Izumi, 2010, Japanese journal of clinical oncology.

Parenchymal Suture-Assisted Inner Suture Method: Tips to Achieve a Reliable Inner Suture in Partial Nephrectomy

K. Izumi, A. Mizokami, K. Shigehara, 2021, Videourology.

Severe Renal Hemorrhage in a Pregnant Woman Complicated with Antiphospholipid Syndrome: A Case Report

K. Izumi, A. Mizokami, M. Namiki, 2011, Advances in urology.

Suprapubic cystostomy during renal transplantation in a patient with a urethral stricture after hypospadias surgery: A case report

K. Nakashima, A. Mizokami, K. Shigehara, 2019, IJU case reports.

Prevalence of N. gonorrhoeae, C. trachomatis, M. genitalium, M. hominis and Ureaplasma spp. in the anus and urine among Japanese HIV-infected men who have sex with men.

H. Yaegashi, K. Nakashima, K. Izumi, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Prevalence of genital Mycoplasma, Ureaplasma, Gardnerella, and human papillomavirus in Japanese men with urethritis, and risk factors for detection of urethral human papillomavirus infection

T. Sasagawa, A. Mizokami, M. Namiki, 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: The role of procalcitonin

H. Yaegashi, K. Izumi, Y. Kitagawa, 2014, International journal of urology : official journal of the Japanese Urological Association.

C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment

Wen-Jye Lin, K. Izumi, A. Mizokami, 2018, Cancer science.

Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal‐related events in patients with prostate cancer with bone metastasis

K. Izumi, A. Mizokami, M. Namiki, 2012, BJU international.

Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2021, In Vivo.

Age‐specific reference range of prostate‐specific antigen and prostate cancer detection in population‐based screening cohort in Japan: Verification of Japanese Urological Association Guideline for prostate cancer

K. Izumi, Y. Kitagawa, A. Mizokami, 2014, International journal of urology : official journal of the Japanese Urological Association.

Cumulative risk of developing prostate cancer in men with low (≤2.0 ng/mL) prostate‐specific antigen levels: A population‐based screening cohort study in Japan

Kazuto Ito, Y. Kitagawa, A. Mizokami, 2014, International journal of urology : official journal of the Japanese Urological Association.

Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: Clinical application and validation

H. Yaegashi, H. Akaza, K. Nakashima, 2013, International journal of urology : official journal of the Japanese Urological Association.

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening

Y. Kitagawa, A. Mizokami, M. Namiki, 2013, Prostate international.

Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1–10.0 ng/ml at population screening

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Journal of Cancer Research and Clinical Oncology.

Clinical outcomes of prostate cancer patients detected by prostate‐specific antigen‐based population screening in Kanazawa City, Japan

Y. Kitagawa, A. Mizokami, M. Namiki, 2011, International journal of urology : official journal of the Japanese Urological Association.

Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer

A. Yokomizo, N. Masumori, Y. Nasu, 2017, International Journal of Clinical Oncology.

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer

K. Izumi, A. Mizokami, T. Makino, 2022, Cancers.

Role of Surgical Resection in Adult Urological Soft Tissue Sarcoma: 25-Year Experience

K. Izumi, Y. Kitagawa, A. Mizokami, 2010, Urologia Internationalis.

α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer

K. Izumi, A. Mizokami, Yohei Saito, 2021, Molecules.

Low free testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors

K. Izumi, A. Mizokami, M. Namiki, 2021, The aging male : the official journal of the International Society for the Study of the Aging Male.

Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study)

H. Yaegashi, S. Yano, Tadaaki Yamada, 2021, Journal of cachexia, sarcopenia and muscle.

Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism.

T. Higashi, A. Mizokami, M. Namiki, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy

H. Yaegashi, K. Izumi, A. Mizokami, 2021, In Vivo.

Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial

Y. Fujii, G. Kimura, K. Izumi, 2019, International Journal of Clinical Oncology.

Novel Prevention Procedure for Inguinal Hernia after Robot-Assisted Radical Prostatectomy: Results from a Prospective Randomized Trial.

H. Yaegashi, K. Nakashima, K. Izumi, 2019, Journal of endourology.

The establishment of two paclitaxel‐resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines

Jian Zhang, E. Keller, A. Mizokami, 2007, The Prostate.

Primary female urethral adenocarcinoma treated with high dose rate brachytherapy, external beam radiotherapy, and chemotherapy

H. Yaegashi, A. Mizokami, M. Namiki, 2014, International Cancer Conference Journal.

Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity

K. Iwata, A. Mizokami, T. Gabata, 2020, Japanese Journal of Radiology.

Clinical results of iridium-192 high dose rate brachytherapy with external beam radiotherapy.

K. Izumi, A. Mizokami, M. Namiki, 2010, Japanese journal of clinical oncology.

Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study)

K. Izumi, A. Mizokami, K. Shigehara, 2020, Andrologia.

Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy

K. Nakashima, K. Izumi, A. Mizokami, 2018, Andrology.

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases

A. Yokomizo, N. Masumori, Y. Nasu, 2019, International Journal of Clinical Oncology.

Risk Scoring System for Ra-223 Discontinuation and Its Effect on Prognosis: A Retrospective Study.

H. Yaegashi, Y. Okada, A. Mizokami, 2021, Cancer diagnosis & prognosis.

An Unusual Prostate-Specific Antigen Decrease in an Advanced Castration-Resistant Prostate Cancer Patient with Intracerebral Hemorrhage Subsequently Treated with Luteinizing Hormone-Releasing Hormone Antagonist

K. Izumi, A. Mizokami, M. Namiki, 2013, Case Reports in Nephrology and Dialysis.

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer

H. Akaza, Y. Enomoto, Kazuhiro Suzuki, 2019, Cancer medicine.

[Androgen receptor mutation].

A. Mizokami, M. Namiki, 2011, Nihon rinsho. Japanese journal of clinical medicine.

CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Wen-Jye Lin, K. Izumi, A. Mizokami, 2018, Cancer science.

Three‐dimensional structure of testis cords in mice and rats

M. Itoh, A. Mizokami, S. Iseki, 2021, Andrology.

788 ABERRANT ACTIVATION OF PARACRINE LOOP BETWEEN PROSTATE CANCER CELLS AND CARCINOMA-ASSOCIATED FIBROBLASTS BY OVEREXPRESSION OF STROMAL INTERLEUKIN-6

K. Iguchi, Y. Iwamoto, A. Mizokami, 2012 .

Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells.

Hong-Chiang Chang, Chawnshang Chang, S. Altuwaijri, 2007, Asian journal of andrology.

Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level

Chiung-Kuei Huang, H. Miyamoto, Wen-Jye Lin, 2014, Journal of Cancer Research and Clinical Oncology.

Androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in castration‐resistant prostate cancer

H. Yaegashi, K. Izumi, A. Mizokami, 2020, The Prostate.

[Prospects for molecular research in urological oncology: bladder cancer].

A. Mizokami, M. Namiki, K. Koshida, 2001, Hinyokika kiyo. Acta urologica Japonica.

Randomized study on the effect of zoledronic acid treatment for prostate cancer with bone metastasis during initial combined androgen blockade.

Y. Kondo, T. Fukagai, A. Mizokami, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.

H. Yaegashi, K. Izumi, A. Mizokami, 2023, Photodiagnosis and photodynamic therapy.

THE EFFECTS OF COX-2 EXPRESSION IN PROSTATE CANCER CELLS : MODULATION OF RESPONSE TO CYTOTOXIC AGENTS

H. Coley, G. Kass, A. Mizokami, 2007 .

Adrenal androgen levels as predictors of outcome in castration‐resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second‐line anti‐androgen

K. Izumi, A. Mizokami, M. Namiki, 2010, International journal of urology : official journal of the Japanese Urological Association.

Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital

H. Yaegashi, K. Nakashima, S. Matsuo, 2019, AntiCancer Research.

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients

S. Morita, N. Nonomura, N. Masumori, 2014, BMC Cancer.

Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?

H. Yaegashi, K. Izumi, A. Mizokami, 2023, AntiCancer Research.

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL

K. Izumi, A. Mizokami, Y. Kadono, 2019, International braz j urol : official journal of the Brazilian Society of Urology.

Factors predictive of oncological outcome after nephroureterectomy: comparison between laparoscopic and open procedures.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.

Efficacy of androgen deprivation therapy for localized prostate cancer: analysis of pT0 evaluated by radical prostatectomy specimen.

H. Yaegashi, K. Izumi, Y. Kitagawa, 2013, Anticancer research.

Urodynamic evaluation before and immediately after robot-assisted radical prostatectomy.

H. Yaegashi, K. Izumi, A. Mizokami, 2014, Urology.

Laparoscopy and Robotics Urodynamic Evaluation Before and Immediately After Robot-assisted Radical Prostatectomy

H. Yaegashi, K. Izumi, A. Mizokami, 2014 .

Aplastic anemia associated with severe hemorrhagic cystitis following radiotherapy for prostate cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2016, Molecular and clinical oncology.

Metanephric adenoma treated with laparoscopic nephrectomy: A case report.

H. Ikeda, K. Izumi, A. Mizokami, 2017, Molecular and clinical oncology.

Postoperative functional and cancer control evaluation of conventional and Retzius‐sparing robot‐assisted radical prostatectomy: Comparison of selected cases by propensity score matching

H. Yaegashi, K. Izumi, A. Mizokami, 2023, The Prostate.

Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.

Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT?

H. Yaegashi, Kotaro Yoshida, K. Izumi, 2022, Cancers.

Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function

H. Yaegashi, K. Izumi, A. Mizokami, 2018, In Vivo.

Comparison of Clinical Outcomes between Robot-Assisted Partial Nephrectomy and Cryoablation in Elderly Patients with Renal Cancer

H. Yaegashi, Kotaro Yoshida, K. Izumi, 2022, Cancers.

A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age

H. Yaegashi, K. Izumi, A. Mizokami, 2020, Asian journal of andrology.

Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy.

K. Izumi, A. Mizokami, M. Namiki, 2009, Urology.

Cardiovascular and respiratory effects of the degree of head‐down angle during robot‐assisted laparoscopic radical prostatectomy

H. Yaegashi, T. Tsubokawa, A. Mizokami, 2013, The international journal of medical robotics + computer assisted surgery : MRCAS.

Carbon dioxide gas embolism during robot‐assisted laparoscopic partial nephrectomy

H. Yaegashi, K. Izumi, A. Mizokami, 2022, IJU Case Reports.

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study

S. Anai, N. Kawai, K. Ishibashi, 2023, Cancers.

Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea

A. Mizokami, M. Namiki, K. Shigehara, 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

Preserved renal function after percutaneous radiofrequency ablation for renal tumors: experience of a single institution.

Y. Kitagawa, A. Mizokami, M. Namiki, 2013, Anticancer Research.

A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

T. Takahara, H. Yaegashi, Y. Yoshioka, 2023, BMC Urology.

Should patients with localized prostate cancer receive primary androgen deprivation therapy?

H. Akaza, A. Mizokami, M. Namiki, 2008, Nature Clinical Practice Urology.

T. Shimada, Y. Sai, K. Izumi, 2017, Journal of pharmaceutical health care and sciences.

Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis

H. Yaegashi, Wen-Jye Lin, K. Izumi, 2022, Cancer Science.

Identification of a New Enhancer in the Promoter Region of Human TR3 Orphan Receptor Gene

Chawnshang Chang, A. Mizokami, Hiroji Uemura, 1995, The Journal of Biological Chemistry.

Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy

K. Izumi, A. Mizokami, K. Shigehara, 2020, The aging male : the official journal of the International Society for the Study of the Aging Male.

The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma

H. Yaegashi, K. Izumi, A. Mizokami, 2020, AntiCancer Research.

Abstract 85: Establishment of cabazitaxel-resistant prostate cancer cell lines

E. Keller, K. Izumi, A. Mizokami, 2017 .

Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types.

Jian Zhang, E. Keller, A. Mizokami, 2014, Critical reviews in oncogenesis.

Regenerative treatment for male stress urinary incontinence by periurethral injection of adipose‐derived regenerative cells: Outcome of the ADRESU study

K. Toriyama, T. Yamanishi, A. Mizokami, 2020, International journal of urology : official journal of the Japanese Urological Association.

OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)

Y. Tanahashi, Terukazu Nakamura, A. Kawauchi, 2020, International journal of urology : official journal of the Japanese Urological Association.

Clinicopathological outcomes of clinical T1a renal cell carcinoma by tumor size.

K. Nakashima, K. Izumi, Y. Kitagawa, 2011, Japanese journal of clinical oncology.

Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report

H. Yaegashi, K. Izumi, A. Mizokami, 2015, Journal of Medical Case Reports.

H. Yaegashi, H. Ikeda, K. Izumi, 2021, Anticancer Research.

Novel α-Trifluoromethyl Chalcone Exerts Antitumor Effects Against Prostate Cancer Cells

H. Yaegashi, K. Izumi, A. Mizokami, 2023, AntiCancer Research.

Cryotreatment against metastatic renal cell bone tumour reduced multiple lung metastases.

H. Tsuchiya, K. Hayashi, Y. Tanzawa, 2011, Anticancer research.

Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study)

M Namiki, T. Iwamoto, Y. Kitagawa, 2018, Andrologia.

Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer

P. Schnepp, E. Keller, J. Escara-Wilke, 2021, BMC Cancer.

Determination of sulfates of androsterone and epiandrosterone in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry.

A. Mizokami, M. Namiki, E. Koh, 2005, Biomedical chromatography : BMC.

Tranilast InhibitsHormoneRefractory Prostate CancerCell ProliferationandSuppressesTransforming Growth Factor b 1-AssociatedOsteoblastic Changes

E. Keller, K. Izumi, Y. Kitagawa, 2009 .

Transvaginal polytetrafluoroethylene mesh surgery for pelvic organ prolapse: 1‐year clinical outcomes

H. Yaegashi, M. Koyama, K. Izumi, 2020, International journal of urology : official journal of the Japanese Urological Association.

CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer

Jian Zhang, E. Keller, K. Izumi, 2010, The Prostate.

Histiocytic sarcoma following combination chemotherapy for primary mediastinal germ cell tumor: a diagnostic dilemma

K. Harada, H. Yaegashi, Yasunori Sato, 2021, International Cancer Conference Journal.

Establishment and characterization of androgen‐independent human prostate cancer cell lines, LN‐REC4 and LNCaP‐SF, from LNCaP

A. Mizokami, M. Namiki, K. Koshida, 2007, International journal of urology : official journal of the Japanese Urological Association.

Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study

Y. Kitagawa, A. Mizokami, M. Namiki, 2011, Prostate Cancer and Prostatic Diseases.

Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan

T. Miki, H. Akaza, O. Ogawa, 2013, International Journal of Clinical Oncology.

The five-year effects of testosterone replacement therapy on lipid profile and glucose tolerance among hypogonadal men in Japan: a case control study

K. Nakashima, K. Izumi, A. Mizokami, 2020, The aging male : the official journal of the International Society for the Study of the Aging Male.

Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial

N. Kawai, K. Ishibashi, H. Enokida, 2017, BMC Cancer.

Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases

K. Nakajima, J. Taki, H. Wakabayashi, 2013, Annals of Nuclear Medicine.

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

A. Mizokami, Jian Zhang, E. Keller, 2001, The Journal of clinical investigation.

Results of conservative treatment of upper urinary tract transitional cell carcinoma

A. Mizokami, Tetsurou Matsumoto, N. Fujimoto, 1999, International journal of urology : official journal of the Japanese Urological Association.

Comparison of postoperative urinary continence and incontinence types between conventional and Retzius‐sparing robot‐assisted radical prostatectomy

H. Yaegashi, K. Izumi, A. Mizokami, 2023, Neurourology and urodynamics.

Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy

Kotaro Yoshida, K. Izumi, A. Mizokami, 2021, Scientific Reports.

Investigating Urinary Conditions Prior to Robot-assisted Radical Prostatectomy in Search of a Desirable Method for Evaluating Post-prostatectomy Incontinence.

K. Nakashima, K. Izumi, A. Mizokami, 2016, Anticancer Research.

Title Outcomes and predictive factors of prostate cancer patients with extremelyhigh prostate-specific antigen level

Chiung-Kuei Huang, H. Miyamoto, K. Izumi, 2017 .

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study

S. Anai, N. Kawai, K. Ishibashi, 2019, Contemporary clinical trials communications.

Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review

H. Yaegashi, K. Izumi, A. Mizokami, 2019, The world journal of men's health.

Contribution of Retzius-sparing robot-assisted radical prostatectomy to the mechanism of urinary continence as demonstrated by dynamic MRI

H. Yaegashi, Kotaro Yoshida, K. Izumi, 2023, Scientific Reports.

Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic

H. Yaegashi, K. Izumi, A. Mizokami, 2022, Cancer science.

Examination of Necessity for Pelvic Drain Placement After Robot-assisted Radical Prostatectomy

Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, 2021, In Vivo.

Four year clinical statistics of iridium‐192 high dose rate brachytherapy

A. Mizokami, M. Namiki, K. Koshida, 2006, International journal of urology : official journal of the Japanese Urological Association.

708P PD-L1 as a predictor of survival in patients with metastatic urothelial carcinoma (mUC) from the phase III DANUBE trial of durvalumab (D) or durvalumab plus tremelimumab (D+T) versus standard of care chemotherapy (SoC)

T. Powles, M. Galsky, A. Gupta, 2021, Annals of Oncology.

Androgen and prostate cancer : the role of primary androgen deprivation therapy in localized prostate cancer

Y. Kitagawa, A. Mizokami, M. Namiki, 2008 .

Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.

H. Yaegashi, H. Ikeda, K. Ohtsubo, 2022, Cancer diagnosis & prognosis.

High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma

H. Yaegashi, K. Izumi, A. Mizokami, 2019, AntiCancer Research.

Successful treatment for metastases from renal cell carcinoma with alternation of interferon-alpha subtypes

A. Mizokami, M. Namiki, Y. Kadono, 2010, International Journal of Clinical Oncology.

Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma

K. Izumi, A. Mizokami, T. Makino, 2023, Biomedicines.

Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma

K. Izumi, A. Mizokami, Y. Kadono, 2023, In Vivo.

Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study.

A. Mizokami, H. Kojima, T. Gabata, 2021, Brachytherapy.

Abstract 1: Interaction of prostate cancer cells with tumor microenvironment promotes EMT and DTCs activation

Yi Lu, Jian Zhang, Evan T. Keller, 2014 .

Optimal screening interval for men with low baseline prostate-specific antigen levels (≤1.0 ng/mL) in a prostate cancer screening program

Y. Kitagawa, A. Mizokami, M. Namiki, 2017, World Journal of Urology.

Immunolocalization of glutathione-peroxidase and androgen receptors in the rat dorsolateral prostate.

A. Mizokami, M. Suzuki, M. Murakoshi, 1993, The Tokai journal of experimental and clinical medicine.

Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer

K. Yeung, Jian Zhang, E. Keller, 2015, The Prostate.

Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal‐related events in patients with prostate cancer with bone metastasis

K. Izumi, A. Mizokami, M. Namiki, 2012, BJU international.

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients

S. Morita, N. Nonomura, N. Masumori, 2014, BMC Cancer.

Resistance to paclitaxel increases the sensitivity to other microenvironmental stresses in prostate cancer cells

S. Mooney, Yu Zeng, R. Getzenberg, 2011, Journal of cellular biochemistry.

Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

Yi Lu, Jian Zhang, A. Mizokami, 2010, Cancer research.

Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma

H. Yaegashi, K. Izumi, A. Mizokami, 2022, In Vivo.

Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.

K. Izumi, Y. Kitagawa, A. Mizokami, 2013, Anticancer research.

Three‐dimensional structure of seminiferous tubules in the Syrian hamster

Yoko Sato, T. Iwamoto, A. Mizokami, 2020, Journal of anatomy.

Summary of the clinical practice manual for late‐onset hypogonadism

Hiroaki Kumano, S. Horie, Y. Akehi, 2023, International journal of urology : official journal of the Japanese Urological Association.